Lionco Pharmaceutical Group Co (SHSE:603669) Accounts Payable & Accrued Expense : ¥80.6 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Accounts Payable & Accrued Expense?

Lionco Pharmaceutical Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥95.0 Mil) to Dec. 2023 (¥109.6 Mil) but then declined from Dec. 2023 (¥109.6 Mil) to Mar. 2024 (¥80.6 Mil).

Lionco Pharmaceutical Group Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥91.7 Mil) to Dec. 2022 (¥85.1 Mil) but then increased from Dec. 2022 (¥85.1 Mil) to Dec. 2023 (¥109.6 Mil).

Lionco Pharmaceutical Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lionco Pharmaceutical Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lionco Pharmaceutical Group Co Accounts Payable & Accrued Expense Chart

Lionco Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

327.68

138.65

91.68

85.11

109.55

Lionco Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															107.47	75.10	95.02	109.55	80.59

Lionco Pharmaceutical Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lionco Pharmaceutical Group Co (SHSE:603669) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

68 Zetang Nedong commercial building, 2nd Floor, Shannan Prefecture, CHN

Website

http://www.lingkang.com.cn

Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.

Lionco Pharmaceutical Group Co (SHSE:603669) Headlines

No Headlines